Global Patient Safety Pharmacoepidemiologist

100 Eli Lilly and Company; Indianapolis (IN); On-site; USD 120,000 - 180,000; Full time

Job summary

Lilly is seeking a Global Patient Safety Pharmacoepidemiologist (GPS PE) in Indianapolis to guide data-driven safety analyses across Lilly products. You will lead observational studies, contribute to risk management strategies, and work with cross-functional teams to support regulatory submissions.

The role requires a PhD in Epidemiology or related Public Health field with strong analytical and epidemiology skills, plus experience with real-world data.

Qualifications

• PhD in Epidemiology or related Public Health field
• Strong analytical and statistical skills
• Experience with real-world data and epidemiology methods

Responsibilities

• Lead observational pharmacoepidemiology studies and designs with cross-functional teams
• Contribute to Risk Management and Real World Evidence safety strategies
• Develop and implement analytical methods for signal detection and risk assessment
• Interpret results for regulatory submissions and communications
• Collaborate with external investigators and third-party organizations as needed
• Provide epidemiology expertise for regulatory documents and responses

Skills

PhD in Epidemiology

Data analysis

Regulatory awareness

Education

PhD in Epidemiology

Tools

Statistical software

Job description

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us. Purpose: The purpose of the Global Patient Safety Pharmacoepidemiologist (GPS PE), reporting into GPS Medical, is to provide scientific and data driven guidance to meet strategic objectives in the generation of data to characterize the safety profile of Lilly products. The GPS PE contributes to cross-functional teams that are responsible for generation of primary data or analysis of secondary data sources to contribute to the assessment of the benefit-risk profile of Lilly products. The GPS PE is responsible for supporting the development and execution of risk management plans; identifying and evaluating potential safety signals, addressing safety questions from regulators, and designing and conducting pharmacoepidemiology studies. The GPS PE role may also entail some in-line or project-level supervisory responsibilities.

Primary Responsibilities:

This job description is intended to provide a general overview of the job requirements at the time it was prepared. The job requirements of any position may change over time and may include additional responsibilities not specifically described in the job description. Not all listed responsibilities will be applicable to all GPS PE roles. Consult with your supervisor regarding your actual job responsibilities and any related duties that may be required for the position.

• Collaborates within a cross-functional team and leads the design and execution of observational studies to ensure high quality, scientifically rigorous pharmacoepidemiology study proposals, protocols, statistical analysis plans, clinical study reports, abstracts/publications and/or presentations.
• Contribute to the Risk Management Strategy/Real World Evidence Safety Strategy for assigned molecule(s).
• Design, coordination, and implementation of observational epidemiological studies (including secondary use dataset studies) on epidemiology disease burden, natural history of disease, and assessment of background rates for identified/potential drug risks.
• Develop new methodologies and appropriately utilize pharmacoepidemiologic tools for the identification and analysis of potential safety signals; apply in-depth epidemiologic methods to address complex research questions.
• Lead the conduct of the pharmacoepidemiology studies internally (when appropriate) and collaborate/contract with external investigators and Third-Party Organizations as needed; provide scientific expertise in interpretation and communication of results of pharmacoepidemiology studies.
• Collaborate on developing strategic analytic tools to support activities such as disease state characterization, signal detection, clarification, and evaluation utilizing multiple data sources (e.g., spontaneous, health claims and electronic health records); partner on the development of new standardized analytic methods for selected regulatory safety documents/submissions (e.g., PBRER/PSUR, ISS, product labels).
• Provides input into regulatory documents such as Risk Management Plans, Periodic Benefit-Risk Evaluation Reports, and responses to regulatory queries.
• Provide epidemiological expertise as it relates to signal detection and signal management for the portfolio.
• Collect and analyze patient population data from literature/other sources to assess disease burden providing support for regulatory submissions (e.g., Orphan Drug Applications, Pediatric Investigation Plans, or Pediatric Study Plans).
• Represent Lilly and coordinate its presence in external epidemiology or drug safety groups.
• Stay updated on regulatory activities (eg, FDA, EMA) related to epidemiology.
• Use external contacts for scientific intelligence through benchmarking projects and forums.
• Deep understanding of RWD and methodology including digital tools.
• Demonstrate knowledge of relevant global regulatory requirements and practices; act as subject matter expert in the development and maintenance of procedures and required tools in the quality system as they relate to epidemiology.
• Develop analytic tools to support activities such as disease state characterization, signal detection, clarification, and evaluation utilizing multiple data sources (e.g., spontaneous, health claims and electronic health records); partner on the development of new standardized analytic methods for selected regulatory safety documents/submissions (e.g., PBRER/PSUR, ISS, product labels).
• Support strategy across lifecycle through evidence generation.
• Contribute to the Risk Management Strategy/RWE Safety Strategy for a molecule.
• Design/execution/interpretation of pharmacoepidemiology studies including design and review of study protocols, SAPs, final study reports, presentations, and manuscripts.
• Provide training, coaching and mentorship demonstrating effective PV strategies and sharing experience and knowledge to further advance the goals of the GPS department and wider enterprise.
• Maintain compliance with Lilly Red Book and corporate policies, Lilly Research Laboratories and Global Patient Safety curriculum.
• Maintaining compliance with the Lilly Corporate Integrity Agreement.
• Foster and support a collaborative working environment that maintains a Team Lilly culture focused on inclusion, innovation, acceleration, and delivery.
• Recruit, mentor, develop, and retain top scientific and drug development talent.
• Assure staff comply with company policies and procedures.
• Understanding the roles and responsibilities of the European Union Qualified Person (QPPV).
• Ensure support is provided to enable the Qualified Person to fulfill all the Qualified Person legal responsibilities.

Minimum Qualification Requirements:

• PhD in Epidemiology or related Public Health field) and 3+ years of experience in scientific research or the pharmaceutical industry.

Other Information/Additional Preferences:

• High-level knowledge of global regulations with respect to drug safety and adverse event reporting
• Strong analytical skills and ability to apply statistical and epidemiological methodology in research projects as well as understanding of risk management strategies and risk minimization programs.
• Competent in the conduct of epidemiology studies; competency in the independent analysis of data and interpretation of results from clinical and epidemiology studies.
• Excellent computer skills; knowledge of statistical software packages to analyze epidemiological data.
• Highly effective written and verbal communication skills.
• Ability to work on multiple projects and function effectively in a fast-paced matrixed environment.
• Ability to prioritize tasks and shift priorities rapidly to meet tight deadlines.
• Ability to influence others (both cross-functionally and within the function) in order to create a positive working environment.
• Excellent teamwork skills.
• Applying AI-driven programming techniques to enhance pharmacoepidemiologic study design, data analysis, and signal detection activities.
• Ability to learn and apply technical knowledge to meet changing project needs.
• Experience using longitudinal national databases, claims databases, or electronic medical records (e.g. GPRD) for epidemiologic research.
• Strategic thinker with proven project execution and innovation experience.

Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form (https://careers.lilly.com/us/en/workplace-accommodation) for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response. Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.

Our employee resource